{{Rsnum
|rsid=6598
|Gene=GIMAP5
|Chromosome=7
|position=150743561
|Orientation=plus
|GMAF=0.3613
|Gene_s=GIMAP1-GIMAP5,GIMAP5
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 9.7 | 42.5 | 47.8
| HCB | 8.8 | 38.0 | 53.3
| JPT | 9.7 | 46.9 | 43.4
| YRI | 38.1 | 47.6 | 14.3
| ASW | 29.8 | 42.1 | 28.1
| CHB | 8.8 | 38.0 | 53.3
| CHD | 11.0 | 48.6 | 40.4
| GIH | 18.8 | 49.5 | 31.7
| LWK | 29.1 | 56.4 | 14.5
| MEX | 10.3 | 43.1 | 46.6
| MKK | 32.1 | 50.0 | 17.9
| TSI | 4.9 | 44.1 | 51.0
| HapMapRevision=28
}}

{{PMID|17641683}} Patients with the minor allele A of [[rs6598]] had an increased prevalence of IA-2 autoantibody levels compared to patients without the minor allele (OR=2.2; Bonferroni-corrected P=0.003). is associated with islet autoimmunity in type I diabetes other autoimmune disease.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}